BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 186.20
+5.20 (2.87%)
May 21, 2026, 10:05 AM HKT
BeOne Medicines AG Company Description
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide.
The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
BeOne Medicines AG
| Country | Hong Kong |
| Founded | 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 12,000 |
| CEO | John Oyler |
Contact Details
Address: 94 Aeschengraben 27 Basel Switzerland | |
| Phone | 41 61 685 19 00 |
Stock Details
| Ticker Symbol | 6160 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | KYG1146Y1017 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| John V. Oyler | Co-Founder, Executive Chairman and Chief Executive Officer |
| Wang Lai Ph.D. | President and Global Head of Research and Development |
| Dr. Xiaodong Wang Ph.D. | Co-Chairman of Scientific Advisory Board, Non-Executive Director and Co-Founder |
| Aaron Rosenberg | Chief Financial Officer |
| Chan Lee | General Counsel, Senior Vice President and Corporate Secretary |
| Titus B. Ball | Vice President and Chief Accounting Officer |
| Marcello Damiani | Chief Technology Officer |
| Liza Heapes | Head of Investor Relations |
| Eleanor Duff Ph.D. | Senior Vice President and Head of Corporate Communications |
| Dr. Mark Lanasa | Senior Vice President and Chief Medical Officer for Solid Tumors |